Glycine

coagulation factor II, thrombin ; Homo sapiens







69 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32556284 A case of thrombomodulin mutation causing defective thrombin binding with absence of protein C and TAFI activation. 2020 Jun 23 1
2 28302935 Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical Hemorrhage. 2017 Apr 13 1
3 22612268 Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect. 2012 Jul 12 1
4 20071328 Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. 2010 Mar 12 1
5 20148533 Enhancement of hydrophobic interactions and hydrogen bond strength by cooperativity: synthesis, modeling, and molecular dynamics simulations of a congeneric series of thrombin inhibitors. 2010 Mar 11 1
6 20233000 Glycine pretreatment ameliorates liver injury after partial hepatectomy in the rat. 2010 Feb 1
7 20236938 Crystal structure of thrombin bound to the uncleaved extracellular fragment of PAR1. 2010 May 14 1
8 19715676 Role of P2 glycine in determining the specificity of antithrombin reaction with coagulation proteases. 2009 Nov 6 1
9 19846563 Mutant N143P reveals how Na+ activates thrombin. 2009 Dec 25 1
10 18585267 Tryptophan-contained peptide-functional nanomaterials as general spectrofluorometric reagents for enzyme. 2008 Jun 30 12
11 17473569 Effect of glycine on the calcium signal of thrombin-stimulated platelets. 2007 Jun 3
12 16797105 The biological activity of the histidine-containing diketopiperazines cyclo(His-Ala) and cyclo(His-Gly). 2006 Nov 1
13 15890651 Energetic and structural consequences of perturbing Gly-193 in the oxyanion hole of serine proteases. 2005 Jul 8 2
14 15998637 Thrombin functions through its RGD sequence in a non-canonical conformation. 2005 Aug 19 1
15 14962227 Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly. 2004 Jan 2
16 12731874 Thermodynamic characterization of the binding of nucleotides to glycyl-tRNA synthetase. 2003 May 13 1
17 12916152 [Human thrombin: enzymatic properties, stability and standardization of preparation]. 2002 Sep-Oct 1
18 11601677 Fast homogeneous assay for plasma procarboxypeptidase U. 2001 Sep 1
19 10801785 Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation. 2000 Jul 7 1
20 11080374 Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C. 2000 Nov 1
21 10497166 Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation. 1999 Oct 1 1
22 9490687 Prothrombin Greenville, Arg517-->Gln, identified in an individual heterozygous for dysprothrombinemia. 1998 Mar 15 1
23 9790668 Allosteric effects of a monoclonal antibody against thrombin exosite II. 1998 Oct 27 1
24 9200692 Role of Leu99 of thrombin in determining the P2 specificity of serpins. 1997 Jun 17 2
25 9005443 Construction and structure-activity relationships of chimeric prourokinase derivatives with intrinsic thrombin-inhibitory potential. 1996 Feb 2
26 7548057 Intermolecular interactions between protein C inhibitor and coagulation proteases. 1995 Oct 10 1
27 7582983 Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity. 1995 Aug 1
28 7744836 Development of a novel recombinant serpin with potential antithrombotic properties. 1995 May 19 2
29 21043620 The Fluid-phase SC5b-9 Terminal Complement Complex Binds to the GPIIb/IIIa Complex of Thrombin-stimulated Human Blood Platelets Inhibiting Platelet Aggregation. 1995 1
30 7756983 The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin. 1994 Dec 1
31 8206990 Mutagenesis of recombinant protein C inhibitor reactive site residues alters target proteinase specificity. 1994 Jun 17 1
32 8136018 Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor. 1993 Dec 2
33 8384827 Importance of the Arg-Gly-Asp triplet in human thrombin for maintenance of structure and function. 1993 Mar 2
34 8415574 The structure of a designed peptidomimetic inhibitor complex of alpha-thrombin. 1993 Jul 1
35 1290488 Thrombin-specific inhibition by and slow cleavage of hirulog-1. 1992 May 1 1
36 1547341 Antithrombin-III-Stockholm: a codon 392 (Gly----Asp) mutation with normal heparin binding and impaired serine protease reactivity. 1992 Mar 15 1
37 1560020 The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. 1992 Apr 15 1
38 1581297 Thrombin hydrolysis of an N-terminal peptide from fibrinogen Lille: kinetic and NMR studies. 1992 May 12 2
39 1631048 Characterization of the interactions of a bifunctional inhibitor with alpha-thrombin by molecular modelling and peptide synthesis. 1992 Jan 1
40 1643115 Diphosphorylation of platelet myosin ex vivo in the initial phase of activation by thrombin. 1992 Jul 22 1
41 1871715 A photometric assay for blood coagulation factor XIII. 1991 May 6 1
42 1988465 An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. 1991 Jan 1
43 2369894 Recombinant human protein C derivatives: altered response to calcium resulting in enhanced activation by thrombin. 1990 Aug 2
44 2719946 Substitution of valine for glycine-558 in the congenital dysthrombin thrombin Quick II alters primary substrate specificity. 1989 Mar 7 1
45 2742826 High-resolution NMR studies of fibrinogen-like peptides in solution: interaction of thrombin with residues 1-23 of the A alpha chain of human fibrinogen. 1989 Apr 4 3
46 2742827 High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen. 1989 Apr 4 1
47 2742828 High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen. 1989 Apr 4 3
48 2928328 Tyrosine-specific protein phosphorylation is regulated by glycoprotein IIb-IIIa in platelets. 1989 Apr 3
49 3071528 A characteristic property of vitamin K-dependent plasma protein Z. 1988 Sep 1
50 3166991 High-resolution NMR studies of fibrinogen-like peptides in solution: resonance assignments and conformational analysis of residues 1-23 of the A alpha chain of human fibrinogen. 1988 Jun 14 1